He is currently on Day 13 of cycle 2 of cisplatin and gencytabine.
He had 1.5L UOP with placement of the foley (per discharge summary, retention reportedly started in the evening of [**2-9**]).
He did not receive morphine or compazine for pain [**3-4**] effects of urinary retention.
Stage IV Nasopharyngeal Carcinoma - [**2165-11-22**] - rhinoscopy with tumor extending into the nasal cavity - [**2165-12-3**] PET-CT - FDG avid mass in nasopharynx, left palatine tonsils, clivus, floor of the sella turcica, posterior nasal cavity, posterior ethmoid air cells, and the sphenoid sinus; enlarged lymph nodes with associated necrosis; lytic bone lesion in right iliac bone - [**2165-12-12**] - Biopsy with squamous cell carcinoma 5.
Mother - died in her 90s 4 siblings - 1 brother died of a cancer (unknown type)  Physical Exam: VS on arrival to floor: 96.5, 112/70, 118 - 140 in Afib (100-120's at [**Hospital1 3278**] per d/c summary), 96% on RA GENERAL: was walking to bathroom with nurses when initially seen; pleasant small elderly Asian male HEENT: MMM, Op clear LUNGS: CTA thrughout CARDIO: irregularly irregular, rapid heart rate, could not distinguish any murmurs ABD: thin,, + BS, soft, NTND MS: no spinal tenderness EXTREMITIES: no edema SKIN: no rashes NEURO: AA, cannot ascertain orientation due to language barrier, was up walking to bathroom without difficulty, gait normal, strength seems to be symmetric and normal (does not cooperate for full neuro exam)   Pertinent Results: [**2166-2-12**] 04:59AM BLOOD WBC-9.1 RBC-3.23* Hgb-10.1* Hct-30.4* MCV-94 MCH-31.2 MCHC-33.2 RDW-16.7* Plt Ct-184 [**2166-2-14**] 02:10AM BLOOD WBC-11.3*# RBC-2.78* Hgb-8.8* Hct-26.1* MCV-94 MCH-31.5 MCHC-33.5 RDW-16.8* Plt Ct-110* [**2166-2-15**] 02:41PM BLOOD Hct-25.8* [**2166-2-15**] 05:42AM BLOOD PT-11.6 PTT-43.4* INR(PT)-1.0 [**2166-2-12**] 04:59AM BLOOD Glucose-148* UreaN-24* Creat-0.9 Na-134 K-3.5 Cl-96 HCO3-27 AnGap-15 [**2166-2-15**] 05:42AM BLOOD Glucose-104* UreaN-28* Creat-0.8 Na-140 K-3.3 Cl-101 HCO3-26 AnGap-16 [**2166-2-12**] 04:59AM BLOOD ALT-18 AST-19 CK(CPK)-29* AlkPhos-152* TotBili-1.2 [**2166-2-12**] 04:59AM BLOOD CK-MB-2 cTropnT-<0.01 [**2166-2-15**] 05:42AM BLOOD Calcium-8.5 Phos-2.3* Mg-1.4* [**2166-2-12**] 04:59AM BLOOD VitB12-566 [**2166-2-12**] 04:59AM BLOOD TSH-1.1 [**2166-2-12**] 03:21AM URINE RBC-50* WBC-1 Bacteri-NONE Yeast-NONE Epi-0 [**2166-2-12**] 03:21AM URINE Blood-MOD Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-TR [**2166-2-12**] 03:21AM URINE Color-Yellow Appear-Clear Sp [**Last Name (un) **]-1.015  [**2166-2-12**] 3:21 am URINE  URINE CULTURE (Final [**2166-2-14**]):  NO GROWTH.
Large soft tissue mass within the nasopharynx, with associated osseous destruction as detailed, which is incompletely imaged and characterized without IV contrast.
Markedly irregular right posterior cerebral artery with high-grade segmental stenosis.
There was gross aspiration with multiple consistencies of barium including thin, nectar, and pudding.
He was transferred with foley in place with good output and no evidence of acute renal failure.
Patient underwent ROMI thich was negative, UA was negative for UTI.
He was started on heparin for anticoagulation.
Ultimately, patient clinically deteriorated in setting of no PO intake, recent stroke with aspiration on video swallow, and afib with RVR requiring diltiazem infusion.
On [**2166-2-16**] a discussion regarding goals of care was again initiated and patient was placed on comfort measures only.
He was given IV Diltiazem for rate control without success.
He was transferred to the MICU where he was placed on a continuous diltiazem infusion with rate control to the 90-100's.
He was then transferred to the cardiology floor on the diltiazem infusion for further management.
Patient's family refused PEG so he was continued on diltiazem infusion until goals of care were changed to comfort measures only.
NG tube unable to be placed due to large nasopharyngeal mass.
Patient's clinical course and prognosis was discussed with his primary oncologist.
Medications on Admission: Diltiazem ER 120 mg QD-- last given on [**2-11**] at 11 am Advair 250/50 [**Hospital1 **] Monteleukast 10 QD ProAir 90 Q6 hours Lidoderm patch QD Senna PEG  Discharge Medications: Deceased  Discharge Disposition: Expired  Discharge Diagnosis: Deceased  Discharge Condition: Deceased  Discharge Instructions: Deceased  Followup Instructions: Deceased
